Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who were randomly assigned to a group in the Hope Study (CA-0011) and completed the full 12 months of participation in that study.
- People who are not able to become pregnant, or who are using a reliable form of birth control.
- People who have a Study Partner (such as a family member or caregiver) who is available and willing to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who did not follow the treatment plan closely enough during the Hope Study (CA-0011).
- People who live full-time in a nursing home or continuous care facility (those in assisted living may still be considered).
- People who are starting or already receiving any of the following treatments during the study: immune-modifying therapies or antibody-based treatments for Alzheimer's disease (such as monoclonal antibodies), the medication memantine (sold as Namenda or Namzaric), or brain-function drugs other than a stable dose of acetylcholinesterase inhibitors.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) at 12-Months; Change from Baseline in a Combined Statistical Test (CST) that creates a composite measure (combining Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) and Mini-Mental State Exam (MMSE) scales into one measure) at 12-Months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.